These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 10419001)

  • 1. Polycystic ovary syndrome: evidence for a primary disorder of ovarian steroidogenesis.
    Franks S; Gharani N; Gilling-Smith C
    J Steroid Biochem Mol Biol; 1999; 69(1-6):269-72. PubMed ID: 10419001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of polycystic ovary syndrome: evidence for a genetically determined disorder of ovarian androgen production.
    Franks S; Gilling-Smith C; Gharani N; McCarthy M
    Hum Fertil (Camb); 2000; 3(2):77-79. PubMed ID: 11844358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism.
    Gharani N; Waterworth DM; Batty S; White D; Gilling-Smith C; Conway GS; McCarthy M; Franks S; Williamson R
    Hum Mol Genet; 1997 Mar; 6(3):397-402. PubMed ID: 9147642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics of polycystic ovary syndrome.
    Franks S; Gharani N; Waterworth D; Batty S; White D; Williamson R; McCarthy M
    Mol Cell Endocrinol; 1998 Oct; 145(1-2):123-8. PubMed ID: 9922108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP17 gene polymorphic sequence variation is associated with hyperandrogenism in Kashmiri women with polycystic ovarian syndrome.
    Ashraf S; Rasool SUA; Nabi M; Ganie MA; Jabeen F; Rashid F; Amin S
    Gynecol Endocrinol; 2021 Mar; 37(3):230-234. PubMed ID: 32456493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian and adrenal hyperandrogenism.
    Carmina E
    Ann N Y Acad Sci; 2006 Dec; 1092():130-7. PubMed ID: 17308139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Polymorphism in CYP11alpha and CYP17 genes and the etiology of hyperandrogenism in patients with polycystic ovary syndrome].
    Pérez MS; Cerrone GE; Benencia H; Márquez N; De Piano E; Frechtel GD
    Medicina (B Aires); 2008; 68(2):129-34. PubMed ID: 18499961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypersecretion of androgens by polycystic ovaries: the role of genetic factors in the regulation of cytochrome P450c17 alpha.
    Franks S; White D; Gilling-Smith C; Carey A; Waterworth D; Williamson R
    Baillieres Clin Endocrinol Metab; 1996 Apr; 10(2):193-203. PubMed ID: 8773744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of insulin resistance in polycystic ovary syndrome.
    Diamanti-Kandarakis E; Papavassiliou AG
    Trends Mol Med; 2006 Jul; 12(7):324-32. PubMed ID: 16769248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycystic ovarian syndrome: signs and feedback effects of hyperandrogenism and insulin resistance.
    Hernández-Jiménez JL; Barrera D; Espinoza-Simón E; González J; Ortíz-Hernández R; Escobar L; Echeverría O; Torres-Ramírez N
    Gynecol Endocrinol; 2022 Jan; 38(1):2-9. PubMed ID: 34787028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology of ovarian steroid secretion in polycystic ovary syndrome.
    Barnes RB
    Semin Reprod Endocrinol; 1997 May; 15(2):159-68. PubMed ID: 9165659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review: fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies.
    Xita N; Tsatsoulis A
    J Clin Endocrinol Metab; 2006 May; 91(5):1660-6. PubMed ID: 16522691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A genetic risk score is associated with polycystic ovary syndrome-related traits.
    Lee H; Oh JY; Sung YA; Chung HW
    Hum Reprod; 2016 Jan; 31(1):209-15. PubMed ID: 26573528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polycystic ovary syndrome in adolescent girls.
    Baldauff NH; Witchel SF
    Curr Opin Endocrinol Diabetes Obes; 2017 Feb; 24(1):56-66. PubMed ID: 27906711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of a DENND1A isoform produces a polycystic ovary syndrome theca phenotype.
    McAllister JM; Modi B; Miller BA; Biegler J; Bruggeman R; Legro RS; Strauss JF
    Proc Natl Acad Sci U S A; 2014 Apr; 111(15):E1519-27. PubMed ID: 24706793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian and adipose tissue dysfunction in polycystic ovary syndrome: report of the 4th special scientific meeting of the Androgen Excess and PCOS Society.
    Yildiz BO; Azziz R;
    Fertil Steril; 2010 Jul; 94(2):690-3. PubMed ID: 19394000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications.
    Nestler JE
    Semin Reprod Endocrinol; 1997 May; 15(2):111-22. PubMed ID: 9165656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgens and polycystic ovary syndrome.
    Nisenblat V; Norman RJ
    Curr Opin Endocrinol Diabetes Obes; 2009 Jun; 16(3):224-31. PubMed ID: 19390322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathogenesis of polycystic ovary syndrome: lessons from ovarian stimulation studies.
    Barnes RB
    J Endocrinol Invest; 1998 Oct; 21(9):567-79. PubMed ID: 9856411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian and adrenal function in polycystic ovary syndrome.
    Rosenfield RL
    Endocrinol Metab Clin North Am; 1999 Jun; 28(2):265-93. PubMed ID: 10352919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.